Stealth Biotechnology Revenue

Biotechnology Research • Hanover, NH Headquarters, United States • 1-10 Employees

Stealth Biotechnology revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Stealth Biotechnology

Ed Feris

Chief Executive Officer

Company overview

Headquarters	Hanover, NH Headquarters, United States
NAICS	541714
Founded	2022
Employees	1-10

About Stealth Biotechnology

We are a stealth-mode biotechnology company advancing breakthrough solutions at the intersection of biology and clinical research. While our work remains confidential, we aim to develop technologies that transform the landscape of human healthcare. Backed by high-profile investors and guided by rigorous science, we're building quietly and with bold ambitions.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Stealth Biotechnology has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Stealth Biotechnology has never raised funding before.

Frequently asked questions

Stealth Biotechnology is located in Hanover, NH Headquarters, US.

Stealth Biotechnology generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Stealth Biotechnology has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Stealth Biotechnology was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

Stealth Biotechnology has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Stealth Biotechnology

Ed Feris

Chief Executive Officer

4.8

40,000 users